Metropolis presents to you a simple blood test (FDA Approved Process) to rule out 8 most prevalent types of cancer: Colon, Lung, Liver, Stomach, Breast, Ovarian, tongue and Pancreas. Just fill the simple form below and our representative will call you to confirm your booking. - See more at: http://www.metropolisindia.com/patients/cancer-eight#sthash.dQJVuc9C.dpuf
DC You Said: Yes you Do..Follow the money and the Federal Trademarks you understand..memory formerly PLS claims they are a subsidiary of Amarantus..That is completely false ..imo..Cannot find any connection to that scenario..But we know this connection is true and a given....Ownership in a Federal trade name is everything in the real world you understand...Something AMBS is touting...
"I do not know who will take the AMBS Diagnostic Division/LymPro, or why it is taking them this long to spin it off. Does it coincide with Provista's stretched time table- I dunno."
"I doubt that Provista will be acquiring LymPro. I also think that they will spin off CIT to focus on their core business expansion plans. It will take deeper pockets at this time, someone familiar will step out from the shadows and claim those prizes."
William has lots and lots of patents and claime to have two for LC Sentinel pending..He also mentioned he was sending the FDA approval to an outside agency that specializes in that process......
"Perhaps the Radient/GCDx/PDx patents are hiding in plain sight, which is often the toughest place to see."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.